Search the Blog

ctDNA and the Future of Lymphoid Cancer Research

In part, my research since joining the SFU faculty has been a logical extension of my PhD thesis. I continue to collaborate with many scientists and clinicians at BC Cancer to study the genetic features of non-Hodgkin lymphomas (NHLs), with emphasis on research questions that will make a difference for patients.

One of the cancers I focus on is diffuse large B-cell lymphoma (DLBCL...

My Path to a Career in Cancer Research (Part III)

The sequencers at the GSC were rapidly gaining improvements in read length and throughput. I spent my time working with the more interesting (and complex) types of data that could be generated, beginning with “transcriptomes” and then “exomes”.

Despite knowing I wanted to do a PhD, I had not yet been convinced of a project that I would want to spend the next three to five years on and...

Advancing cancer care with new technology

The BC Cancer Agency is recognized as one of the world’s leading cancer care and research centres. We’ve achieved this in large part by being able to attract some of the best talent. But having the brightest minds will only take you so far if you don’t give them the latest tools and equipment. That’s why in our quest for new knowledge, the BC Cancer Foundation is investing in new technology...

Conquering cancer on two wheels

In my previous post I mentioned the BC Cancer Agency’s OVCARE team and the great work they’ve done to position themselves as one of the world’s leading ovarian cancer research teams. They’re not only conquering cancer in the lab, but they’re also doing it on two wheels.

With its many supporters, OVCARE has participated every year in The Ride to Conquer Cancer, and is one of the top...

Leaning on Darwin’s thinking

In previous posts I wrote about matching treatment to the patient’s tumour. Currently, we choose treatments primarily based on what the lymphoma looks like down the microscope.

At this time, we treat all patients who have diffuse large B-cell lymphoma, the most common form of lymphoma, with one chemotherapy recipe called R-CHOP. This works quite well, curing about 60 percent of...

How donors are accelerating scientific discovery

The other day I spent time with some BC Cancer Foundation donors, talking about lymphoma research and taking them on a tour of the lab. Later, I reflected on the role that philanthropy plays in supporting cancer research in general and my research specifically.

During our discussion, I was asked a number of great questions, and all had the same theme—recent innovations in technology or...

Personal Experience Motivates this Doctor

As a Clinician-Scientist at the BC Cancer Agency, I spend part of my time looking after patients with lymphoma and part of my time doing lymphoma research.

I grew up in a small rural community south of Auckland, New Zealand – the youngest of six children. From a young age, I was exposed to the challenges of medicine, as my father was a doctor, mainly looking after people with diabetes...


Subscribe to Lymphoid cancers